The 2025-2026 respiratory viral season is approaching. With it comes the familiar challenge of protecting our most vulnerable patients — those who have undergone hematopoietic cell...
by ASTCT Advocacy Update
On Wednesday, November 12, the U.S. House of Representatives voted to approve the U.S. Senate’s proposal to reopen the federal government, ending the longest government shutdown in history.
by David Porter
In this message, ASTCT President Dr. David Porter provides an update on the society’s upcoming strategic plan, which will guide ASTCT from 2026 through 2028. He explains the three pillars...
by Dr. Olalekan Oluwole, MD, MPH
This spotlight features ASTCT Board member Olalekan Oluwole, MD, MPH, a hematologist–oncologist specializing in stem cell transplantation and cellular therapy, and the director of the...
Hematopoietic cell transplantation can be lifesaving, but it’s also one of the most demanding treatments patients and families will ever face.
ASTCT’s Palliative and Supportive...
by ASTCT Talks
In this episode of ASTCT’s Titans of Transplant series, Dr. Taha Al-Juhaishi welcomes Dr. Sattva Neelapu of MD Anderson Cancer Center for a deep and insightful conversation on the evolution,...